Home » Center Research Publications » Controversies Concerning Mitochondrial Replacement Therapy

Controversies Concerning Mitochondrial Replacement Therapy

Klitzman R, Toynbee M, Sauer M. Controversies concerning mitochondrial replacement therapy. Fertility and Sterility 2015;103(2):344-346.


Get Full Text

Research on mitochondrial replacement therapy (MRT) holds the promise of helping women who have, or are at risk of transmitting, mitochondrial disease, but has recently been blocked by the Food and Drug Administration (FDA). Thus, several critical ethical and policy questions arise. Mitochondrial disease can be devastating for those who have it. Yet existing treatments remain supportive rather than curative. Women confronting this disease have a high chance of having an affected child and limited reproductive alternatives.